Aligos Therapeutics Inc. (ALGS)
NASDAQ: ALGS
· Real-Time Price · USD
7.70
0.12 (1.52%)
At close: Aug 15, 2025, 3:59 PM
7.70
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
1.52% (1D)
| Bid | 7.41 |
| Market Cap | 47.37M |
| Revenue (ttm) | 3.17M |
| Net Income (ttm) | -74.18M |
| EPS (ttm) | -13.27 |
| PE Ratio (ttm) | -0.58 |
| Forward PE | -0.85 |
| Analyst | Buy |
| Ask | 8 |
| Volume | 54,377 |
| Avg. Volume (20D) | 99,866 |
| Open | 7.69 |
| Previous Close | 7.58 |
| Day's Range | 7.42 - 7.84 |
| 52-Week Range | 3.76 - 46.80 |
| Beta | 2.77 |
About ALGS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALGS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Aligos Therapeutics has released their quartely earnings
on Aug 6, 2025:
Next Earnings Release
Aligos Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
-19.55%
Aligos Therapeutics shares are trading lower after...
Unlock content with
Pro Subscription
6 months ago
-19.25%
Aligos Therapeutics shares are trading lower after the company announced a $105 million private placement financing round.
